Author

Yanick Mulumba

Institution: Intellia Therapeutics (United States)

Observed institution: Intellia Therapeutics (United States)

OpenAlex ID: A5010956590

CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease

2017 · Vionnie W.C. Yu, Yi Liu, et al. · Blood · 6

Works count: 1

Citation count: 6

H-index: 1

I10-index: